LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology

    08/02/2024
    POSITION PAPER

    The EU biotech and biomanufacturing initiative is a unique opportunity for the EU to take urgent and immediate actions to support the scale up of the EU biotech and biomanufacturing sector. This must be coupled with a regulatory environment that encourages investments in research and development, fosters innovation and market access. The EU must also provide incentives that attract the best in class for skills, in both business and biomanufacturing.

    Building on its strong science and research base, and the EU Commission’s recent announcements on its ambition for European leadership in new technologies, Europe now needs to create impact from these good intentions and to reinforce its competitiveness.

    We have identified specific key asks for a globally competitive EU Industrial biotechnology sector that delivers sustainable innovative solutions.

    1. Need for harmonised national and EU frameworks for enabling biotechnology;
    2. Address regulatory hurdles to accelerate market access and enhance global competitiveness;
    3. Improve access to feedstock and recognition of sustainability;
    4. Support infrastructure scale up and improve access to skills.

    We call on these specific key asks to be considered in the forthcoming European Commission Biotechnology and Biomanufacturing initiative alongside 5 common cross-sectoral principles.

    EU biotech and biomanufacturing Initiative: Key asks for Industrial Biotechnology


    Download

    Share
    Communications Team
    Communications Team

    Related posts

    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more
    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more

    Important links

    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies
    • Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.